Skip to main content

Table 5 Unmet coordination needs

From: A survey of cancer patients’ unmet information and coordination needs in handovers – a cross-sectional study

  Overall unmet coordination needs Unmet coordination needs in handovers between hospital and GP# Unmet coordination needs in handovers between internal hospital departments## Unmet coordination needs at handovers between hospitals###
  N (%) OR (95% CI) ORadja(95% CI) N (%) OR (95% CI) ORadja(95% CI) N (%) OR (95% CI) ORadja(95% CI) N (%) OR (95% CI) ORadja(95% CI)
Demographic characteristics
Gender
 Women 19 (19%) 1.00 1.00 17 (20%) 1.00 1.00 8 (9%) 1.00 1.00 14 (18%) 1.00 1.00
 Men 5 (15%) 0.74 (0.25; 2.18) 1.10 (0.31; 3.93) 4 (13%) 0.63 (0.19; 2.06) 0.88 (0.25; 3.09) 2 (6%) 0.74 (0.15; 3.69) 2.53 (0.37; 17.47) 5 (24%) 1.45 (0.46; 4.62) 1.85a(0.48; 7.07)
Age
 <60 years of age 14 (36%) 1.00 1.00 9 (29%) 1.00 1.00 7 (19%) 1.00 1.00 9 (29%) 1.00 1.00
 ≥60 years of age 10 (11%) 0.22*(0.09; 0.55) 0.26*(0.10; 0.70) 12 (14%) 0.40 (0.15; 1.06) 0.44 (0.16; 1.25) 3 (3%) 0.16*(0.04; 0.65) 0.14*(0.03; 0.68) 10 (14%) 0.41 (0.15; 1.15) 0.46b(0.15; 1.37)
Marital status
 No Partner 5 (18%) 1.00 1.00 3 (12%) 1.00 1.00 2 (7%) 1.00 1.00 4 (18%) 1.00 1.00
 Partner 19 (19%) 1.05 (0.33; 3.13) 1.06 (0.32; 3.50) 18 (20%) 1.81 (0.49; 6.71) 2.05 (0.51; 8.16) 8 (8%) 1.12 (0.22; 5.59) 1.52 (0.24; 9.55) 15 (19%) 1.07 (0.32; 3.63) 0.91c(0.25; 3.28)
Education
 Not higher education 7 (10%) 1.00 1.00 8 (12%) 1.00 1.00 1 (1%) 1.00 1.00 7 (13%) 1.00 1.00
 Higher education 16 (29%) 3.06*(1.36; 9.52) 3.41*(1.23; 9.44) 13 (28%) 2.91*(1.09; 7.73) 2.82*(1.04; 7.63) 9 (17%) 13.02*(1.60; 106.25) 14.22*(1.61; 125.79) 11 (26%) 2.31 (0.81; 6.59) 2.47d(0.82; 7.37)
Clinical characteristics
Comorbidity
 No comorbidity 10 (25%) 1.00 1.00 6 (18%) 1.00 1.00 5 (13%) 1. 00 1.00 7 (21%) 1.00 1.00
 Yes comorbidity 12 (14%) 0.49 (0.19; 1.26) 0.75 (0.26; 2.13) 14 (18%) 0.99 (0.35; 2.84) 1.24 (0.41; 3.80) 5 (6%) 0.44 (0.12; 1.63) 0.83 (0.19; 3.67) 11 (17%) 0.82 (0.28; 2.34) 1.15c(0.35; 3.78)
Treatment
Surgery
 No surgery 3 (9%) 1.00 1.00 5 (16%) 1.00 1.00 2 (6%) 0.55 1.00 3 (14%) 1.00 1.00
 Surgery 21 (22%) 2.89 (0.80; 10.41) 2.98 (0.35; 25.77) 16 (19%) 1.27 (0.42; 3.81) 0.37 (0.05; 3.04) 8 (9%) 1.43 (0.29; 7.08) 0.63 (0.04; 9.04) 16 (21%) 1.55 (0.41; 5.91) 6.06c(0.33; 110.58)
Radiation
 No radiation 9 (18%) 1.00 1.00 6 (13%) 1.00 1.00 4 (8%) 1.00 1.00 7 (27%) 1.00 1.00
 Radiation 15 (19%) 1.09 (0.44; 2.73) 1.26 (0.44; 3.56) 15 (21%) 1.74 (0.62; 4.88) 1.80 (0.60; 5.42) 6 (8%) 0.96 (0.26; 3.58) 1.14 (0.26; 5.01) 12 (16%) 0.53 (0.18; 1.55) 0.57c(0.18; 1.82)
Chemotherapy
 No chemotherapy 8 (13%) 1.00 1.00 7 (12%) 1.00 1.00 4 (7%) 1.00 1.00 10 (23%) 1.00 1.00
 Chemotherapy 16 (24%) 2.08 (0.82; 5.27) 1.10 (0.30; 4.06) 14 (24%) 2.22 (0.82; 6.00) 1.91 (0.49; 7.44) 6 (9%) 1.35 (0.36; 5.04) 0.54 (0.07; 4.17) 9 (16%) 0.67 (0.24; 1.82) 0.34c(0.08; 1.38)
Hormones
 No hormones 9 (30%) 1.00 1.00 9 (38%) 1.00 1.00 2 (7%) 1.00 1.00 5 (23%) 1.00 1.00
 Hormones 15 (15%) 0.41 (0.16; 1.07) 0.45 (0.15; 1.33) 12 (13%) 0.25*(0.09; 0.70) 0.21*(0.07; 0.66) 8 (8%) 1.24 (0.25; 6.20) 1.39 (0.23; 8.55) 14 (18%) 0.75 (0.24; 2.39) 0.87c(0.24; 3.11)
Years since diagnosis
 <3 years 12 (20%) 1.00 1.00 11 (22%) 1.00 1.00 6 (10%) 1.00 1.00 8 (17%) 1.00 1.00
 ≥3 years 12 (17%) 0.83 (0.34; 2.01) 0.99 (0.35; 2.78) 10 (15%) 0.66 (0.26; 1.71) 0.61 (0.21; 1.76) 4 (6%) 0.56 (0.15; 2.10) 0.73 (0.16; 3.38) 11 (22%) 1.38 (0.50; 3.38) 1.98c(0.63; 6.25)
  1. aAdjusted for age, gender and education, *P < 0.050, #Consists of 117 patient responses, ##Consists of 125 patient responses, ###Consists of 100 patient responses.